ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 10 filers reported holding ESSA PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $6,374,000 | +1273.7% | 33,371,212 | +1473.2% | 6.52% | +1311.0% |
| Q4 2017 | $464,000 | -24.6% | 2,121,212 | 0.0% | 0.46% | -7.8% |
| Q3 2017 | $615,000 | -47.3% | 2,121,212 | 0.0% | 0.50% | -53.3% |
| Q2 2017 | $1,167,000 | -82.4% | 2,121,212 | 0.0% | 1.07% | -78.2% |
| Q1 2017 | $6,618,000 | +42.5% | 2,121,212 | 0.0% | 4.93% | +61.0% |
| Q4 2016 | $4,645,000 | -20.4% | 2,121,212 | 0.0% | 3.06% | -14.6% |
| Q3 2016 | $5,833,000 | -6.8% | 2,121,212 | 0.0% | 3.58% | -34.5% |
| Q2 2016 | $6,257,000 | -9.2% | 2,121,212 | 0.0% | 5.47% | +5.8% |
| Q1 2016 | $6,894,000 | – | 2,121,212 | – | 5.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,090,909 | $6,884,000 | 3.88% |
| DAFNA Capital Management LLC | 228,500 | $1,424,000 | 1.41% |
| ACUTA CAPITAL PARTNERS, LLC | 288,400 | $1,797,000 | 1.04% |
| AWM Investment Company, Inc. | 727,272 | $4,552,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,859,282 | $11,580,000 | 0.45% |
| ACADIAN ASSET MANAGEMENT LLC | 17,900 | $113,000 | 0.00% |
| MORGAN STANLEY | 12,500 | $72,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 1,000 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 800 | $5,000 | 0.00% |
| ROYAL BANK OF CANADA | 200 | $1,000 | 0.00% |